[4] These medications are typically prescribed in conjunction with a reduced-calorie diet and increased physical activity, as part of a comprehensive weight management program such as ours here at Rivas medical Weight Loss Potential Benefits Beyond Glycemic Control While GLP-1 agonists are primarily used for blood sugar control and weight management in type 2 diabetes, they also show promise in providing additional health benefits
Cortistatin has zero human studies for any indication Current Practical Access DSIP DSIP can be administered subcutaneously and is available from research peptide suppliers
Systemic inflammation at low doses: In animal models, even low doses or a single dose of semaglutide were shown to reduce TNF- and other inflammatory signals within hours of an inflammatory challenge Human trials suggest anti-inflammatory benefits at sub-weight loss (low) doses: Multiple trials (SUSTAIN, PIONEER, STEP, and others) show reductions in hsCRP and other inflammatory markers at low doses, in some datasets, only a portion of this effect is explained by changes in weight or blood sugar
Across the telehealth GLP-1 market as of April 2026, all-in monthly totals tend to land somewhere between roughly $200 and $700 or more, with wide variance driven by the choices below
Cycling advantages include reduced annual costs through intermittent purchasing (30-40% savings vs continuous use), potentially improved responsiveness when restarting after breaks avoiding adaptation, psychological freedom from continuous dependency, and accommodation of life changes, travel, or budget fluctuations